Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cyclic GMP-AMP synthase (cGAS), upon cytosolic DNA stimulation, catalyzes the formation of the second messenger 2'3'-cGAMP, which then binds to stimulator of interferon genes (STING) and activates downstream signaling. It remains to be elucidated how the cGAS enzymatic activity is modulated dynamically. Here, we reported that the ER ubiquitin ligase
RNF185
interacted with cGAS during HSV-1 infection. Ectopic-expression or knockdown of
RNF185
respectively enhanced or impaired the IRF3-responsive gene expression. Mechanistically,
RNF185
specifically catalyzed the K27-linked poly-ubiquitination of cGAS, which promoted its enzymatic activity. Additionally,
Systemic Lupus Erythematosus
(
SLE
) patients displayed elevated expression of
RNF185
mRNA. Collectively, this study uncovers
RNF185
as the first E3 ubiquitin ligase of cGAS, shedding light on the regulation of cGAS activity in innate immune responses.
...
PMID:The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response. 2827 61